esketamine
Term · Oncology and biomedicine · MLC-T-ONC-013430
A cyclohexanone derivative and S-enantiomer of racemic ketamine, with analgesic, anesthetic and antidepressant activities. Although the mechanism of action is not fully understood, upon administration, esketamine targets, non-competitively binds to, and blocks N-methyl D-aspartate (NMDA) receptors. This reduces pain perception, induces sedation, and produce dissociative anesthesia.
| Identifier | MLC-T-ONC-013430 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | L-ketamine; ketamine, S- |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013430",
"term": "esketamine",
"field": "Oncology and biomedicine",
"definition": "A cyclohexanone derivative and S-enantiomer of racemic ketamine, with analgesic, anesthetic and antidepressant activities. Although the mechanism of action is not fully understood, upon administration, esketamine targets, non-competitively binds to, and blocks N-methyl D-aspartate (NMDA) receptors. This reduces pain perception, induces sedation, and produce dissociative anesthesia.",
"synonyms": [
"L-ketamine",
"ketamine, S-"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/esketamine/"
}
Record 6,896 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.